Xcelerate (OTCMKTS:XCRT) versus Fresenius SE & Co. (OTCMKTS:FSNUY) Financial Contrast

Xcelerate (OTCMKTS:XCRT) and Fresenius SE & Co. (OTCMKTS:FSNUY) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Xcelerate and Fresenius SE & Co., as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xcelerate	0	0	0	0	0.00
Fresenius SE & Co.	0	0	2	1	3.33

Valuation and Earnings

This table compares Xcelerate and Fresenius SE & Co.”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xcelerate	N/A	N/A	N/A	N/A	N/A
Fresenius SE & Co.	$23.63 billion	N/A	$509.67 million	$0.19	64.79

Fresenius SE & Co. has higher revenue and earnings than Xcelerate.

Profitability

This table compares Xcelerate and Fresenius SE & Co.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Xcelerate	N/A	N/A	N/A
Fresenius SE & Co.	1.92%	9.06%	4.17%

Volatility and Risk

Xcelerate has a beta of 4.08, indicating that its stock price is 308% more volatile than the S&P 500. Comparatively, Fresenius SE & Co. has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500.

Summary

Fresenius SE & Co. beats Xcelerate on 7 of the 8 factors compared between the two stocks.

About Xcelerate

Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.

About Fresenius SE & Co.

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.